223 related articles for article (PubMed ID: 31638193)
1. Cancer‑associated adipocytes exhibit distinct phenotypes and facilitate tumor progression in pancreatic cancer.
Cai Z; Liang Y; Xing C; Wang H; Hu P; Li J; Huang H; Wang W; Jiang C
Oncol Rep; 2019 Dec; 42(6):2537-2549. PubMed ID: 31638193
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated adipocytes promote pancreatic cancer progression through SAA1 expression.
Takehara M; Sato Y; Kimura T; Noda K; Miyamoto H; Fujino Y; Miyoshi J; Nakamura F; Wada H; Bando Y; Ikemoto T; Shimada M; Muguruma N; Takayama T
Cancer Sci; 2020 Aug; 111(8):2883-2894. PubMed ID: 32535957
[TBL] [Abstract][Full Text] [Related]
3. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
[No Abstract] [Full Text] [Related]
4. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
[TBL] [Abstract][Full Text] [Related]
5. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells' heterogeneity.
Schlesinger Y; Yosefov-Levi O; Kolodkin-Gal D; Granit RZ; Peters L; Kalifa R; Xia L; Nasereddin A; Shiff I; Amran O; Nevo Y; Elgavish S; Atlan K; Zamir G; Parnas O
Nat Commun; 2020 Sep; 11(1):4516. PubMed ID: 32908137
[TBL] [Abstract][Full Text] [Related]
6. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming.
Cai Z; Li Y; Ma M; Wang L; Wang H; Liu M; Jiang C
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264956
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
[TBL] [Abstract][Full Text] [Related]
8. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Hiroshima Y; Kasajima R; Kimura Y; Komura D; Ishikawa S; Ichikawa Y; Bouvet M; Yamamoto N; Oshima T; Morinaga S; Singh SR; Hoffman RM; Endo I; Miyagi Y
Cancer Lett; 2020 Jan; 469():217-227. PubMed ID: 31669204
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
10. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
11. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.
Zhu K; Cai L; Cui C; de Los Toyos JR; Anastassiou D
PLoS Comput Biol; 2021 Jul; 17(7):e1009228. PubMed ID: 34283835
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
14. Adipocytes WNT5a mediated dedifferentiation: a possible target in pancreatic cancer microenvironment.
Zoico E; Darra E; Rizzatti V; Budui S; Franceschetti G; Mazzali G; Rossi AP; Fantin F; Menegazzi M; Cinti S; Zamboni M
Oncotarget; 2016 Apr; 7(15):20223-35. PubMed ID: 26958939
[TBL] [Abstract][Full Text] [Related]
15. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
[TBL] [Abstract][Full Text] [Related]
16. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer.
Ikenaga N; Ohuchida K; Mizumoto K; Cui L; Kayashima T; Morimatsu K; Moriyama T; Nakata K; Fujita H; Tanaka M
Gastroenterology; 2010 Sep; 139(3):1041-51, 1051.e1-8. PubMed ID: 20685603
[TBL] [Abstract][Full Text] [Related]
17. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism.
Shan T; Chen S; Chen X; Lin WR; Li W; Ma J; Wu T; Cui X; Ji H; Li Y; Kang Y
Oncol Rep; 2017 Apr; 37(4):1971-1979. PubMed ID: 28260082
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion.
Dirat B; Bochet L; Dabek M; Daviaud D; Dauvillier S; Majed B; Wang YY; Meulle A; Salles B; Le Gonidec S; Garrido I; Escourrou G; Valet P; Muller C
Cancer Res; 2011 Apr; 71(7):2455-65. PubMed ID: 21459803
[TBL] [Abstract][Full Text] [Related]
20. Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.
Bhagat TD; Von Ahrens D; Dawlaty M; Zou Y; Baddour J; Achreja A; Zhao H; Yang L; Patel B; Kwak C; Choudhary GS; Gordon-Mitchell S; Aluri S; Bhattacharyya S; Sahu S; Bhagat P; Yu Y; Bartenstein M; Giricz O; Suzuki M; Sohal D; Gupta S; Guerrero PA; Batra S; Goggins M; Steidl U; Greally J; Agarwal B; Pradhan K; Banerjee D; Nagrath D; Maitra A; Verma A
Elife; 2019 Nov; 8():. PubMed ID: 31663852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
